Fas signaling is involved in the control of hair follicle response to chemotherapy

Cancer Research

Volumn 64, Issue 17, 2004, Pages 6266-6270

  Sharov, Andrei A ^a   Siebenhaar, Frank ^a,b   Sharova, Tatyana Y ^a   Botchkareva, Natalia V ^a,c   Gilchrest, Barbara A ^a   Botchkarev, Vladimir A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Gillette Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYCLOPHOSPHAMIDE; FAS LIGAND; LIGAND; NEUTRALIZING ANTIBODY; PROTEIN P53;

ALOPECIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; FAS ASSOCIATED DEATH DOMAIN; HAIR FOLLICLE; HAIR LOSS; HUMAN; IN VIVO STUDY; KERATINOCYTE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODIES; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CARRIER PROTEINS; CASPASE 8; CASPASES; CYCLOPHOSPHAMIDE; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HAIR FOLLICLE; IN SITU NICK-END LABELING; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 4344708351     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1367     Document Type: Article

References (24)

1. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999;341:491-7.
2. Botchkarev VA. Molecular mechanisms of chemotherapy-induced hair loss, J Investig Dermatol Symp Proc 2003;8:72-5.
3. Botchkarev VA, Komarova EV, Siebenhaar F, et al. p53 is essential for chemotherapy-induced hair loss. Cancer Res 2000;60:5002-6.
4. Davis ST, Benson BG, Bramson HN, et al. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science 2001;291:134-7.
5. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030-40.
6. Gudkov AV, Komarova EA. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 2003;3:117-29.
7. Manfredi J. p53 and apoptosis: it's not just in the nucleus anymore. Mol Cell 2003;11:552-4.
8. Curtin JF, Cotter TG. Live or let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signalling 2003;15:983-92.
9. Friesen C, Herr I, Krammer PH, Debatin KM. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 1996;2:574-7.
10. Muller M, Strand S, Hug H. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Investig 1997;99:403-13.
11. Maecker HL, Koumenis CG, Giaccia AG. p53 promotes selection for Fas-mediated apoptotic resistance. Cancer Res 2000;60:4638-44.
12. Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 1999;285:898-900.
13. Peter ME, Krammer PH. The CD95(Apo-1/Fas) DISC and beyond. Cell Death Differ 2003;10:26-35.
14. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997; 151:1601-17.
15. Paus R, Handjiski B, Eichmuller S, Czarnetzki BM. Chemotherapy-induced alopecia in mice: induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol 1994;144:719-34.
16. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Limphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1993;356:314-7.
17. Paus R, Schilli MB, Handjiski B, Menrad A, Henz BM, Plonka P. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res 1996;56:4438-43.
18. Sharov AA, Weiner L, Sharova T, et al. Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J 2003;22:2992-3003.
19. Sharov AA, Li GZ, Palkina TN, Sharova TY, Gilchrest BA, Botchkarev VA. Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Investig Dermatol 2003;120:27-35.
20. Botchkarev VA, Botchkareva NV, Roth W, et al. Noggin is a mesenchymally-derived stimulator of hair follicle induction. Nat Cell Biol 1999;1:158-64.
21. Botchkarev VA, Botchkareva NV, Albers KM, et al. A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J 2000; 14:1931-42.
22. Muller-Rover S, Handjiski B, van der Veen C, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Investig Dermatol 2001;117:3-15.
23. Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000;14:981-93.
24. Mitsui S, Ohuchi A, Hotta M, Tsuboi R, Ogawa H. Genes for a range of growth factors and cyclin-dependent kinase inhibitors are expressed by isolated human hair follicles. Br J Dermatol 1997;137:693-8.